The immunohistochemical profile was strongly positive for cytoplasmic staining of PSA, cytokeratin monoclonal antibodies AE1/AE3, and prostate-specific acid phosphatase (PSAP), but negative for nuclear PSA staining, confirming the tumor as brain metastatic prostate adenocarcinoma (Figure 2). The gene discussed is KLK3; the disease is neoplasm.